Impact of Combining Immune Checkpoint Inhibitors with Chemotherapy in the Management of Advanced Serous Endometrial Adenocarcinoma

Hamadoun Traoré, Andy J Kouanga, Choukri Elm’hadi, Ait Sahel Omar, Rachid Tanz, Hassan Errihani

Open source

DOI
10.9734/jammr/2024/v36i65463
Published
2024-06-02
Container
Journal of Advances in Medicine and Medical Research
Publisher
Sciencedomain International
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.9734/jammr/2024/v36i65463,
  title = {Impact of Combining Immune Checkpoint Inhibitors with Chemotherapy in the Management of Advanced Serous Endometrial Adenocarcinoma},
  author = {Hamadoun Traoré and Andy J Kouanga and Choukri Elm’hadi and Ait Sahel Omar and Rachid Tanz and Hassan Errihani},
  year = {2024},
  journal = {Journal of Advances in Medicine and Medical Research},
  doi = {10.9734/jammr/2024/v36i65463},
  url = {https://doi.org/10.9734/jammr/2024/v36i65463}
}

RIS

TY  - JOUR
TI  - Impact of Combining Immune Checkpoint Inhibitors with Chemotherapy in the Management of Advanced Serous Endometrial Adenocarcinoma
AU  - Hamadoun Traoré
AU  - Andy J Kouanga
AU  - Choukri Elm’hadi
AU  - Ait Sahel Omar
AU  - Rachid Tanz
AU  - Hassan Errihani
PY  - 2024
JO  - Journal of Advances in Medicine and Medical Research
DO  - 10.9734/jammr/2024/v36i65463
UR  - https://doi.org/10.9734/jammr/2024/v36i65463
ER  - 

APA

Traoré, H., Kouanga, A. J., Elm’hadi, C., Omar, A. S., Tanz, R., & Errihani, H. (2024). Impact of Combining Immune Checkpoint Inhibitors with Chemotherapy in the Management of Advanced Serous Endometrial Adenocarcinoma. Journal of Advances in Medicine and Medical Research. https://doi.org/10.9734/jammr/2024/v36i65463

Source records